30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

LAVA Therapeutics NV (LVTX)

Track

The most recent insider trading activity occurred on October 17, 2025. Significant sell-offs were noted from Cooperatieve Gilde Healthcare IV U.A. and Versant Venture Capital VI, L.P. during September and October 2025, totaling millions in value. No buy transactions were reported in this period.
Stock chart
Ticker: LVTX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Cooperatieve Gilde Healthcare IV U.A.
1 sale — total 1,736,263 USD
Sale 17 Oct 2025
Value US$4,322,311.72 | Price 406.96 | Shares 46,893
Sale 16 Oct 2025
Value US$3,476,501.29 | Price 38.25 | Shares 61,339
Sale 14 Oct 2025
Value US$343,284.91 | Price 1.51 | Shares 227,341
Sale 13 Oct 2025
Value US$73,436.44 | Price 1.54 | Shares 47,686
Sale 10 Oct 2025
Value US$77,296.95 | Price 1.55 | Shares 49,869
Sale 9 Oct 2025
Value US$75,143.64 | Price 1.56 | Shares 48,169
Sale 8 Oct 2025
Value US$45,457.78 | Price 1.57 | Shares 28,954
Sale 19 Sep 2025
Value US$746,764.02 | Price 1.40 | Shares 532,870
Sale 19 Sep 2025
Value US$3,322,064.95 | Price 1.40 | Shares 2,370,533
Sale 18 Sep 2025
Value US$329,870.86 | Price 1.44 | Shares 228,791
Sale 18 Sep 2025
Value US$527,858.84 | Price 1.44 | Shares 366,111
Sale 17 Sep 2025
Value US$337,640.36 | Price 1.49 | Shares 226,726
Sale 17 Sep 2025
Value US$540,290.70 | Price 1.49 | Shares 362,806
Sale 16 Sep 2025
Value US$294,823.63 | Price 1.53 | Shares 192,293
Sale 16 Sep 2025
Value US$471,776.37 | Price 1.53 | Shares 307,707
Proposed sale 5 Jun 2023
Value US$1,743,450.80 | Price 2.60 | Shares 670,558
Sale 20 Oct 2015
Value US$1,460,000.00 | Price 1.46 | Shares 1,000,000
Sale 15 Oct 2015
Value US$302,000.00 | Price 1.51 | Shares 200,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-20 2025-10-17 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
46,893 -11.9%
406.96
US$4,322,312 		46,893 -11.9% 406.96 US$4,322,312
2025-10-20 2025-10-16 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
61,339 -21.1%
38.25
US$3,476,501 		61,339 -21.1% 38.25 US$3,476,501
2025-10-15 2025-10-14 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
11,206 +10.0%
405.86
US$1,404,078 		11,206 +10.0% 405.86 US$1,404,078
2025-10-15 2025-10-13 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
47,686 -0.9%
1.54
US$73,436 		47,686 -0.9% 1.54 US$73,436
2025-10-10 2025-10-10 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
49,869 -0.9%
1.55
US$77,297 		49,869 -0.9% 1.55 US$77,297
2025-10-10 2025-10-09 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
48,169 -0.9%
1.56
US$75,144 		48,169 -0.9% 1.56 US$75,144
2025-10-10 2025-10-08 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
28,954 -0.5%
1.57
US$45,458 		28,954 -0.5% 1.57 US$45,458
2025-09-23 2025-09-19 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
532,870 -100.0%
1.40
US$746,764 		532,870 -100.0% 1.40 US$746,764
2025-09-23 2025-09-19 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
2,370,533 -100.0%
1.40
US$3,322,065 		2,370,533 -100.0% 1.40 US$3,322,065
2025-09-18 2025-09-18 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
228,791 -30.0%
1.44
US$329,871 		228,791 -30.0% 1.44 US$329,871
2025-09-18 2025-09-18 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
366,111 -13.4%
1.44
US$527,859 		366,111 -13.4% 1.44 US$527,859
2025-09-18 2025-09-17 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
226,726 -22.9%
1.49
US$337,640 		226,726 -22.9% 1.49 US$337,640
2025-09-18 2025-09-17 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
362,806 -11.7%
1.49
US$540,291 		362,806 -11.7% 1.49 US$540,291
2025-09-18 2025-09-16 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
192,293 -16.3%
1.53
US$294,824 		192,293 -16.3% 1.53 US$294,824
2025-09-18 2025-09-16 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
307,707 -9.0%
1.53
US$471,776 		307,707 -9.0% 1.53 US$471,776
2023-06-05 2023-06-05 PrS Proposed sale
2.3
Novo Holdings A/S

10% Stockholder

Large shareholder
670,558
2.60
US$1,743,451 		670,558 2.60 US$1,743,451
2025-10-20 2015-10-20 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
1,000,000 -33.9%
1.46
US$1,460,000 		1,000,000 -33.9% 1.46 US$1,460,000
2025-10-15 2015-10-15 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
200,000 -4.0%
1.51
US$302,000 		200,000 -4.0% 1.51 US$302,000
Explore more

More insider trading research around LAVA Therapeutics NV

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America